Literature DB >> 824198

Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity.

J F Borel.   

Abstract

Cell-mediated cytolysis (CMC) was assayed in a system using spleen cells from mice (C57BL/6) sensitized with allogeneic tumour cells (DBA/2 mastocytoma P-815). Anti-inflammatory drugs, immunosuppressives, inhibitors of cell division and other agents were investigated for their capacity to inhibit CMC in three different ways. First, inhibition of CMC after in vitro addition of drug was observed with corticosteroids, some immunosuppressives and inhibitors of cell division. Secondly, suppression of CMC after a single drug administration to sensitized mice shortly before being killed was found with corticosteroids, several immunosuppressives and irradiation. Thirdly, prevention of development of CMC by repeated drug treatment (immunosuppressive schedule) was achieved with most immunosuppressives and cytostatic drugs. Non-steroidal anti-inflammatory drugs were inactive in these tests. Correlation of effects between the three procedures was very poor and it is suggested that various mechanisms may be involved in the different assays.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 824198      PMCID: PMC1445361     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Effect of some drugs on the chemotaxis of rabbit neutrophils in vitro.

Authors:  J F Borel
Journal:  Experientia       Date:  1973-06-15

2.  Interruption of the sequential release of small and large molecules from tumor cells by low temperature during cytolysis mediated by immune T-cells or complement.

Authors:  E Martz; S J Burakoff; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

3.  Hydrocortisne resistance of graft vs host activity in mouse thymus, spleen and bone marrow.

Authors:  J J Cohen; M Fschbach; H N Claman
Journal:  J Immunol       Date:  1970-11       Impact factor: 5.422

Review 4.  On the mechanism of T-cell mediated cytolysis.

Authors:  C S Henney
Journal:  Transplant Rev       Date:  1973

5.  Reversible inhibition of lymphocyte-mediated cytotoxicity by cytochalasin B.

Authors:  J C Cerottini; K T Brunner
Journal:  Nat New Biol       Date:  1972-06-28

6.  Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia.

Authors:  P Dombernowsky; N I Nissen
Journal:  Acta Pathol Microbiol Scand A       Date:  1973-09

7.  Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction.

Authors:  G A Granger; W P Kolb
Journal:  J Immunol       Date:  1968-07       Impact factor: 5.422

8.  Studies of allograft immunity in mice. II. Mechanism of target cell inactivation in vitro by sensitized lymphocytes.

Authors:  J Mauel; H Rudolf; B Chapuis; K T Brunner
Journal:  Immunology       Date:  1970-04       Impact factor: 7.397

9.  Properties of colchicine binding protein from chick embryo brain. Interactions with vinca alkaloids and podophyllotoxin.

Authors:  L Wilson
Journal:  Biochemistry       Date:  1970-12-08       Impact factor: 3.162

Review 10.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.

Authors:  J C Cerottini; K T Brunner
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

View more
  57 in total

1.  History of clinical transplantation.

Authors:  T E Starzl
Journal:  World J Surg       Date:  2000-07       Impact factor: 3.352

2.  Cyclosporin A: friend or foe?

Authors:  S Epstein
Journal:  Calcif Tissue Int       Date:  1991-10       Impact factor: 4.333

Review 3.  Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.

Authors:  Agnieszka Swiatecka-Urban
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

4.  Experience with cyclosporine and steroids in clinical renal transplantation.

Authors:  N L Tilney; E L Milford; J L Araujo; T B Strom; C B Carpenter; R L Kirkman
Journal:  Ann Surg       Date:  1984-11       Impact factor: 12.969

5.  Inhibition of mouse natural killer activity by cyclosporin A.

Authors:  R H Yanagihara; W H Adler
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

6.  Vascularized whole knee joint allografts in rabbits immunosuppressed with cyclosporin A.

Authors:  J M Siliski; S Simpkin; C J Green
Journal:  Arch Orthop Trauma Surg       Date:  1984

7.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Authors:  J F Borel; C Feurer; C Magnée; H Stähelin
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

Review 8.  Signaling cascades as drug targets in model and pathogenic fungi.

Authors:  Robert J Bastidas; Jennifer L Reedy; Helena Morales-Johansson; Joseph Heitman; Maria E Cardenas
Journal:  Curr Opin Investig Drugs       Date:  2008-08

9.  Hepatic and renal function in rats receiving immunotherapeutic doses of cyclosporin A.

Authors:  P H Whiting; A W Thomson; I D Cameron; J G Simpson
Journal:  Br J Exp Pathol       Date:  1980-12

10.  Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.

Authors:  N R Sinclair
Journal:  CMAJ       Date:  1992-09-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.